PLUS THERAPEUTICS FILES 8-K: Accountant Change & Financials

Ticker: PSTV · Form: 8-K · Filed: Jul 18, 2025 · CIK: 1095981

Plus Therapeutics, Inc. 8-K Filing Summary
FieldDetail
CompanyPlus Therapeutics, Inc. (PSTV)
Form Type8-K
Filed DateJul 18, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: accountant-change, financials, disclosure

TL;DR

PLUS THERAPEUTICS changed accountants and filed financials on 7/16.

AI Summary

On July 16, 2025, PLUS THERAPEUTICS, INC. (formerly CYTORI THERAPEUTICS, INC. and MACROPORE INC) filed an 8-K report. The filing indicates a change in the registrant's certifying accountant and includes financial statements and exhibits. The company is incorporated in Delaware and its principal executive offices are located in Houston, Texas.

Why It Matters

This filing signals a change in the company's auditing firm, which could impact financial reporting transparency and investor confidence. It also includes updated financial statements.

Risk Assessment

Risk Level: low — The filing is a routine disclosure of a change in certifying accountant and submission of financial exhibits, with no immediate indication of financial distress or significant operational changes.

Key Numbers

  • 001-34375 — SEC File Number (Identifies the company's filing with the SEC.)
  • 33-0827593 — IRS Employer Identification No. (Company's tax identification number.)

Key Players & Entities

  • PLUS THERAPEUTICS, INC. (company) — Registrant
  • CYTORI THERAPEUTICS, INC. (company) — Former Company Name
  • MACROPORE INC (company) — Former Company Name
  • July 16, 2025 (date) — Date of earliest event reported
  • Delaware (jurisdiction) — State of incorporation
  • Houston, Texas (location) — Address of principal executive offices

FAQ

What is the specific reason for the change in PLUS THERAPEUTICS, INC.'s certifying accountant?

The filing does not specify the reason for the change in the certifying accountant, only that a change has occurred.

When was the change in the certifying accountant effective?

The change in the registrant's certifying accountant was effective as of July 16, 2025.

What are the former names of PLUS THERAPEUTICS, INC. mentioned in the filing?

The filing lists the former names as CYTORI THERAPEUTICS, INC. (name change effective July 12, 2005) and MACROPORE INC (name change effective March 20, 2001).

Where are PLUS THERAPEUTICS, INC.'s principal executive offices located?

The principal executive offices of PLUS THERAPEUTICS, INC. are located at 2710 Reed Road, Suite 160, Houston, Texas 77051.

What items are being reported in this 8-K filing?

This 8-K filing reports on Item 4.01 (Changes in Registrant's Certifying Accountant) and Item 9.01 (Financial Statements and Exhibits).

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on July 18, 2025 regarding PLUS THERAPEUTICS, INC. (PSTV).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.